Wird geladen...
Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis
BACKGROUND: Cardiovascular disease (CVD) is the main cause of death among hemodialysis (HD) patients. The effects of the dipeptidyl peptidase-4 inhibitor teneligliptin on CVD-related biomarkers in patients with type 2 diabetes mellitus (T2DM) receiving HD treatment are poorly understood. To determin...
Gespeichert in:
| Veröffentlicht in: | Int J Gen Med |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4835142/ https://ncbi.nlm.nih.gov/pubmed/27110135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S102070 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|